Combined Lomustine and Asparaginase for Treatment of Canine Cutaneous T-cell Lymphoma

Patient Disease:

Cutaneous T-cell Lymphoma

Study Name:

Combined Lomustine and Asparaginase for Treatment of Canine Cutaneous T-cell Lymphoma: Frog-002

Purpose of the study:

To evaluate the efficacy of combining lomustine with asparaginase for dogs with cutaneous T-cell lymphoma

Primary Eligibility Criteria:

Diagnosis by biopsy of cutaneous T-cell lymphoma

Study Protocol:

  • Determine eligibility: Physical exam, lab work, documented diagnosis (biopsy)

  • Day 0: Physical exam, treat with chemotherapy and start prednisolone

  • Ongoing rechecks: Physical exam, lab work, chemotherapy, assessments of response through day 84

  • Then one-month rechecks following treatment

Owner Responsibilities:

  • To make and keep all appointments for the study protocol

  • Administration of oral medications at home

  • Commit to completing study protocol and follow up rechecks

Financial Incentives:

  • Asparaginase is provided at no cost
     


    If you have further questions about any of our clinical trials, please submit an online consulting form. Your consult will then be directed to an appropriate oncology clinician. Requests are typically returned within 5 business days.